Overcoming the barriers of the P53 dysfunction to cure blood cancers

Exciting new immunosuppressive therapy treatment for aplastic anaemia

Combination therapy with idelalisib better prevents disease progression in relapsed or treatment-resistant chronic lymphocytic leukaemia than current regimen

Study underscores promise of targeted therapies as first-line approach for patients with chronic lymphocytic leukaemia

Exciting evidence for first all-oral treatment for relapsed and treatment-resistant multiple myeloma

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival

Variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

Immunotherapy makes patients’ tumours "melt away"

Quality assessment looking at rivaroxaban for cancer-related thrombosis

Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia